Phlox Therapeutics
Seed Round in 2024
Phlox Therapeutics is a biotechnology company focused on developing gene therapies for heart diseases. It works on approaches to alleviate and cure cardiomyopathies and other genetic cardiac conditions by advancing gene therapy and RNA-based therapeutics, with the goal of delivering lifelong benefits to patients and reducing the impact of disease-causing mutations. The company's programs aim to translate genetic insight into therapies that address the root causes of cardiac disorders and offer the potential to halt progression or restore heart function.
Flavour
Venture Round in 2024
Flavour is a technology company that specializes in Applied Gaming and Storytelling. It develops games designed to integrate fun into daily work life, using gamification and hero-centered design methods. The company aims to help users change their behavior positively, thereby contributing to the betterment of organizations and society.
Aurea Imaging
Series A in 2024
Aurea Imaging specializes in software engineering and geographic information systems, focusing on agricultural services and data analysis. The company develops unmanned aerial vehicle technology that leverages geographic information systems and earth observation techniques. This technology conducts spectral analysis to classify geological features and lithology from hyperspectral data collected via sensors on satellites and aircraft. By integrating this analysis with additional information, Aurea Imaging enhances geological maps and identifies potential mineral concentrations on the surface. Their commitment to accurate and consistent data collection, processing, and analysis ensures that their products meet the specific needs of clients, enabling effective investigation of environmental changes.
NEFFA develops fully automated production technology for sustainable, vegan textiles and on-demand, custom-fit apparel. The company combines a digital design interface and 3D-based workflows to generate textures and patterns, which are turned into affordable, recyclable molds using low-heat, low-pressure processes. This enables seamless production with minimal waste and on-demand manufacturing, creating cost-efficient opportunities for fashion brands to offer eco-friendly products. NEFFA's biomaterial approach centers on mycelium-derived materials, such as MycoTEX, produced in fermentation tanks, and the system is adaptable to other liquid-fermentable biomaterials like algae or collagen. By shortening design-to-product cycles and enabling precise, customized fits, NEFFA aims to reduce resource use and environmental impact in textile production.
Cordys Analytics
Seed Round in 2023
Cordys Analytics specializes in AI-driven cardiac diagnostics. It develops an AI-based platform that interprets electrocardiograms (ECGs), enabling healthcare providers to detect heart illnesses more efficiently and affordably. This platform aims to improve cardiac care by offering timely, accurate diagnoses close to patients, reducing the burden on healthcare systems.
Pltfrm
Venture Round in 2023
Pltfrm is a technology platform designed to enhance collaboration between IT service providers and clients. By creating a marketplace for various IT services—such as application development, workplace management, cybersecurity, cloud services, marketing, and consulting—Pltfrm allows businesses to connect with specialized providers tailored to their specific needs. The platform simplifies the management of these relationships through features like secure communication, feedback tools, and the formation of a unique IT ecosystem, enabling efficient and effective solutions. Pltfrm aims to transform the way independent contractors and businesses work together, making the process of engaging freelancers seamless and straightforward.
FourOneFour
Seed Round in 2023
The FourOneFour platform makes it easy and dependable to adhere to EU legislation pertaining to sustainable financing.
Neurolytics
Seed Round in 2023
Neurolytics empowers small businesses in candidate selection using objective behavioral analytics via its SaaS solution. The platform employs AI and video technology to assess candidates remotely, helping hiring teams make data-driven decisions.
Cleara Biotech
Seed Round in 2022
Cleara Biotech B.V. is a biotechnology company based in Utrecht, the Netherlands, focused on developing innovative therapeutics to selectively eliminate senescent and senescent-like cancer cells. The company specializes in creating FOXO4-based anti-senescence drugs aimed at addressing chemotoxicity and combating therapy-resistant cancer cells. Cleara Biotech's research targets a crucial aspect of cancer treatment by aiming to enhance the effectiveness of therapies and improve patient outcomes through the targeted removal of problematic cell populations.
Sensoterra
Venture Round in 2022
Sensoterra specializes in the development of wireless soil moisture sensors aimed at enhancing agricultural and landscaping practices. By providing real-time monitoring capabilities at an economical price, Sensoterra's sensors enable growers and landscapers to accurately assess soil moisture levels. This technology addresses the pressing issue of water scarcity, as agriculture accounts for 70% of global freshwater usage, often leading to over-irrigation by up to 60%. Such inefficiencies not only waste water and money but also harm soil health. Sensoterra's sensors empower users to make informed decisions, potentially reducing water consumption by up to 30%. By integrating with existing water management platforms, their solutions contribute to more sustainable irrigation practices, benefiting both agricultural productivity and the broader community.
Prolira BV
Venture Round in 2022
Prolira BV is a medical technology company based in Utrecht, the Netherlands, founded in 2015. It specializes in developing DeltaScan, an innovative EEG-based medical device designed for the early detection of delirium, a form of acute brain failure. The DeltaScan system comprises a single-use electrode patch known as the DeltaScan Patch and a hardware/software module called the DeltaScan Monitor, which analyzes brain activity to support clinical decision-making. Prolira is dedicated to enabling timely and effective treatment for acute encephalopathy and delirium, conditions that affect approximately 20 million patients annually in hospitals across the European Union and the United States. By providing the first EEG bedside device with a validated proprietary algorithm, Prolira aims to help clinicians optimize patient recovery, ultimately reducing long-term cognitive impairment and hospital costs.
Prepr is a technology company that specializes in data-driven headless content management software, aimed at enhancing content data management and multichannel publishing. It has developed a unique headless content management system (CMS) that integrates a built-in personalization engine, enabling businesses to deliver personalized digital content at scale. This all-in-one platform allows organizations, particularly in the media sector, to create, manage, and publish content while also optimizing customer experiences through features such as lean customer profiles, real-time segments, and content targeting. By simplifying the content management process, Prepr helps companies lower development costs and accelerate time-to-market, making it a valuable tool for forward-thinking businesses looking to maximize the impact of their content.